Editorial: Phony cloner
By Sacramento Bee,
The Sacramento Bee
| 12. 29. 2005
Can California's $3 billion stem cell institute learn something from the misdeeds of South Korean scientist Hwang Woo-Suk?
It can, but only if leaders of the Institute for Regenerative Medicine take the time to publicly grapple with this scandal. So far, they have acted as if Hwang is a distant aberration whose fabrications don't affect them. Nothing could be further from the truth.
As a column on the opposite page notes, Hwang was once the world's master "cloner" in creating lines of embryonic stem cells. Last Friday, he admitted faking key parts of his research and resigned from Seoul National University.
Hwang's methods first came under scrutiny when some of his colleagues accused him of buying human eggs from his underlings, a breach of ethical protocol. Now investigators are examining if Hwang broke other rules and faked other studies.
While California's institute can do only so much to combat scientific fraud - the responsibility lies largely in the hands of peer-reviewed journals - it can set standards for obtaining eggs and other biological material, and ensure those rules are enforced...
Related Articles
By Dr. Coco Newton, Progress Educational Trust | 03.30.2026
Have you ever wondered what it means to have dozens of half-siblings across the world – or to never know where half of your genetic identity comes from? A recent episode of Zembla explores the human consequences of the global...
By Marcelo Jauregui-Volpe, Wired | 04.24.2026
Two companies that launched last year with plans to create gene-edited babies have already shut down, citing money issues and internal conflict.
One of them, Manhattan Genomics of New York, closed abruptly shortly after announcing a team of scientific advisers...
By Alexandre Piquard, Le Monde [cites Katie Hasson] | 04.27.2026
"Si on en prouve la sûreté, nous croyons que l’édition préventive du génome pourrait être l’une des technologies de santé les plus importantes du siècle. » Lucas Harrington explique ainsi le but de son entreprise Preventive : créer des bébés génétiquement modifiés...
By Abby Vesoulis, Mother Jones | 04.18.2026
Two years ago, we devoted an entire issue to the rise of the American oligarchy. Since then, our oligarchic system has become more entrenched and pervasive, revolving around a small crew of tech titans whose quest for wealth and...